| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |